Guangdong Pharmaceutical University was founded in 1958. It is one of the three pharmaceutical universities in the country. It is the first institution of higher learning in South China to offer a series of pharmacy majors. The basic major of integrated traditional Chinese and Western medicine is a key specialty of the State Administration of Traditional Chinese Medicine. The pharmacy major is a key advantageous discipline in Guangdong Province. The clinical medicine discipline ranks among the top 1% of ESI globally and continues to this day. Guangzhou Fosun Chancheng Hospital of Guangdong Pharmaceutical University (Guangzhou Xinshi Hospital) was established in 2003. It is a tertiary general hospital integrating medical treatment, teaching, scientific research, and preventive health care with a complete set of disciplines.
Guangzhou Fosun Chancheng Hospital of Guangdong Pharmaceutical University (Guangzhou Xinshi Hospital) is located at No. 79, Xinshi Xin Street, Baiyun District, Guangzhou City, Guangdong Province. It currently has more than 54 clinical medical technology departments, more than 800 open beds, and more than 1,000 health technicians. Among them, 116 have senior professional titles and 223 have intermediate professional titles.
International Minimally Invasive Oncology Diagnosis and Treatment Center
The Cancer Center of Guangzhou Fosun Chancheng Hospital (Guangzhou Xinshi Hospital) is a key construction discipline of the hospital. It has 5 wards and 167 open beds. It is the director unit of the Oncology Subcommittee of the Guangzhou Baiyun District Medical Association. The center is led by authoritative experts such as the famous tumor immunology expert Chen Tao, interventional cancer experts Professor Luo Pengfei, Professor Zhou Zejian, and Professor Tan Jingwang, and has gathered a group of experienced cancer experts such as Wang Jian, Peng Qirong, Tang Rijie, Zhang Dongxing, Jia Yun, and Sun Zhengyu to form a strong multidisciplinary diagnosis and treatment team.
The center adopts a multidisciplinary diagnosis and treatment model (MDT) and vigorously develops unique tumor treatment technologies based on traditional surgery, chemotherapy, and radiotherapy. Featured technologies include precise minimally invasive interventional therapy for tumors, argon-helium cryotherapy, microwave ablation, stent implantation, iodine 125 seed implantation, autologous bone marrow and blood transplantation, and integrated traditional Chinese and Western medicine treatments. The center is particularly good at targeting various common high-incidence malignant tumors, focusing on minimally invasive interventional therapy and combining a variety of treatment methods to formulate individualized comprehensive treatment plans for patients, providing diversified treatment options for tumor patients at different stages.
In addition, the establishment of the hospital’s International Medical Center and International Minimally Invasive Oncology Diagnosis and Treatment Center has further integrated the hospital’s 9 key tumor-related departments and more than 30 authoritative expert resources to provide better medical services to patients from Guangdong, Hong Kong, Macao, Taiwan and international countries.
